Skip to content

oncoFISH Cervical Test for Detection of 3q26 Region Gain

The oncoFISH Cervical Test for Detection of 3q26 Region Gain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01416922
Enrollment
1100
Registered
2011-08-15
Start date
2009-06-30
Completion date
2011-12-31
Last updated
2011-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, LSIL

Brief summary

The purpose of this study is to evaluate the use of the oncoFISH cervical test system in the management of women who have received an LSIL Pap report to determine whether the test can predict which women will progress to more serious cervical disease and which women do not have to be monitored as closely.

Interventions

None listed

Sponsors

Ikonisys, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women 21 years of age or greater with recent LSIL who are scheduled for colposcipal assessment. * Women with previous or current STD or HIV may be included * Women with previous LSIL history may be included.

Exclusion criteria

* pregnant women, * women with vaginal intraepithelial lesions, * women on a chemotherapeutic agent, * women with previous or current cancer except for non-cervical squamous cell carcinoma

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026